LSIPR attended a packed UK Supreme Court yesterday for day one of a four-day hearing, with Warner-Lambert debating the role that plausibility plays in patent law. The case revolves around the drug pregabalin, which has historically been used to treat anxiety disorder and epilepsy. Part of Pfizer …
